Market Assessment

Objective :

Evaluation of the market potential of the asset gained through the acquisition

Problem Statement:

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new class of drug showed the potential in targeting multiple tumors in combination with their in-house immune checkpoint inhibitor (CPI). The assessment formed the basis of their decision to either retain or divest the product later.

Our Methodology:

• Extensive Secondary Research
• Extensive Primary Research
• Competitive Benchmarking
• Clinical Trials Analysis
• Strategic Insights on Companies
• Forecasting

Results:

• Executive analysis, Information on therapy area, disease overview, unmet need, treatment algorithm, market drivers and barriers & SWOT analysis of the product/Indication
• Competitive landscape for marketed and pipeline products
• Detailed attribute analysis of the key competitor products
• Market size in terms of value and volume of marketed and pipeline products
• Detailed forecast for the acquired asset of interest and our final recommendation on investing/divesting